or
Bookmark and Share
Alkali-treated bagasse, and its preparation and uses
   
Document Number
US Patent 5545418
Issued Date
August 13, 1996
Link
Map
Abstract
An alkali-treated bagasse is prepared by softening a bagasse with calcium oxide together with or without sodium hydroxide while preventing the substantial decomposition of cellulose and hemicellulose, a bagasse feed and a fermented bagasse feed prepared from the alkali-treated bagasse, and their preparations and uses as well as bacteria for fermenting the alkali-treated bagasse.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
21
Comments:
no comments yet
Published
August 13, 1996
Application Number
08/364,489
Filed
December 27, 1994
US Classification
426/53   426/61 426/635
Int'l Classification
A23K   1/12   (20060101)   A23K   1/00   (20060101)   C05F   5/00   (20060101)   C12P   19/00   (20060101)   C12P   19/04   (20060101)  
Assistant Examiner
Attorney/Law Firm
Priority Data
Dec 27, 1993 [JP] 5-346818
USPTO Field of Search
426/53   426/635   426/61  
Related Patents
6077546 - Quick-fermented feed and method of preparing - Owned by Kabushiki Kaisha Hayashibara Seibutsu (Okayama,JP)

A quick-fermented feed is prepared by incorporating plant concentrate materials into alkali-treated wastes of agricultural products to lower the pH to a level below 10, inoculating the mixture with lactic acid bacteria capable of growing under alkaline conditions or high salt conditions, and fermenting the resulting mixture.

5747020 - Bacterial treatment for silage - Owned by Pioneer Hi-Bred International, Inc. (Des Moines, IA)

Silage is preserved by treatment with a small, but silage preserving effective amount of a seven strain inoculant, in which five of the strains are members of the Lactobacillus plantarum taxon and the remaining two strains are members of the Enterococcus faecium taxon. This seven strain inoculant is particularly effective in improving the aerobic stability as well as the rate and extent of digestibility of whole plant corn silage. It is also effective in improving animal milk and meat performance when animals are fed inoculated silage.

6174275 - Processes for immobilizing waste using bagasse - Owned by Nicholls State University (Thibodaux, LA)

A process for solidifying and stabilizing waste, the process comprising (a) combining bagasse and a liquid medium having a pH below about 4 or above about 10 to form a mixture, (b) heating the mixture, (c) separating the mixture into solid matter and filtrate and washing the solid matter with a liquid in which sugar is soluble, (d) substituting the solid matter for the bagasse in (a) and repeating steps (a) through (c) until the filtrate is substantially colorless under ambient light conditions, thereby producing washed solid matter, (e) combining at least a portion of the washed solid matter with at least (1) the waste, (2) water, and (3) a cement, so as to form a cement slurry, and (f) curing the cement slurry. Cementitious products formed by processes of this invention.

6783775 - Serum-derived factor inducing cell differentiation and medical uses thereof - Owned by Hadasit Medical Research Services and Development Ltd. (Jerusalem,IL)

The present invention relates to a biologically active serum-derived composition of matter (SDF), having a low molecular weight, being electrically charged at acidic pH and having absorption at 280 nm. The molecular weight of said SDF was determined by electron spray mass spectrometry and is of 316 Da. SDF of the present invention or its complex with ceruloplasmin (CP) have several therapeutic properties. For example, SDF or its complex with CP is capable of inducing terminal cell differentiation of leukemic cells, which as a result, may lose their ability to proliferate and their ability for self cell renewal. Further, SDF or the complex with CP is capable of stimulating the proliferation of early, normal progenitor cells and inhibiting enhanced angiogenesis. In addition, SDF or its complex with CP is capable of ex vivo expanding normal stem and progenitor cells. The invention also relates to pharmaceutical composition comprising as active ingredient SDF or its complex and optionally further comprising pharmaceutically acceptable additives. Such pharmaceutical compositions may be for inhibiting enhance angiogenesis, for inducing remission of tumors, for maintaining tumor remission, and for expanding hematopoietic normal stem and progenitor bone marrow transplants.

7189306 - Process of treating lignocellulosic material to produce bio-ethanol

This invention relates to a process of treating a lignocellulosic material to produce bio-ethanol. The process includes the steps of: (a) exposing the lignocellulosic material to conditions including a pH not less than about 8, and steam at a first pressure, to produce a step (a) product; (b) explosively discharging the step (a) product to a second pressure less than the first pressure to produce a step (b) product; and (c) further processing the step (b) product to produce bio-ethanol and other co-products. In another embodiment, the invention relates to a conical auger fractionation column. The fractionation column includes a column body having an input and an output. A conical filter is positioned inside the column body, the filter having a larger diameter end directed toward the input and a smaller diameter end directed toward the output. A conical auger is positioned inside the conical filter, the conical auger having an outer diameter which is approximately the same as an inner diameter of the conical filter. The auger and filter are adapted to cooperate to separate cellulosic solids from a liquid stream in a process of producing bio-ethanol from a lignocellulosic material.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us